Speaker
Prof. Tae-Ho Hwang
Pusan National University, South Korea
Biography :
Professor Taeho Hwang is a faculty member at Pusan National University School of Medicine and a renowned immunologist. He has played a pivotal role in early-phase clinical studies of the Vaccinia Oncolytic Virus and has conducted reverse translational research based on in-depth immune analyses of preclinical and clinical studies over the past 23 years. He is a co-founder of Bionox Inc. (S. Korea) and recently got US FDA Phase 1 clinical trial of immune-modulating oncolytic virus. His current research in Bionoxx and PNU focuses on T cell modulation through the regulation of neutrophil plasticity, with related studies underway in preparation for clinical application.
